Two-Piece Craniotomy Is Associated With Improved Postoperative Outcomes of Combined Revascularization in Patients With Moyamoya Disease

对于烟雾病患者,两段式开颅术与联合血管重建术后疗效的改善相关。

阅读:1

Abstract

BACKGROUND: Revascularization for both anterior cerebral artery (ACA) and middle cerebral artery (MCA) territories in patients with moyamoya disease is often performed in a single operation. The influence of craniotomy type on postoperative outcomes has not been investigated. This study aimed to clarify the effects of craniotomy type on acute postoperative outcomes after combined revascularization by comparing 2-piece, and large 1-piece craniotomy approaches. METHODS: This retrospective study included 337 consecutive combined revascularizations of the ACA and MCA territories in patients with moyamoya disease. Surgeries were classified into 2-piece and large 1-piece craniotomy groups. For indirect bypass, the following methods were used: (1) large 1-piece craniotomy and encephalo-myo-galeo-periosteal-synangiosis for the MCA and ACA territories; (2) 2-piece craniotomy and encephalo-myo-synangiosis for the MCA territory and encephalo-periosteal-synangiosis for the ACA territory. Acute postoperative outcomes were compared between the groups. RESULTS: Two-piece and large 1-piece craniotomies were performed in 230 and 107 patients, respectively. The incidence of radiological and symptomatic infarction tended to be lower in the 2-piece craniotomy group than that in the large 1-piece craniotomy group (3.9% versus 11.2%; P=0.014, and 2.6% versus 6.5%; P=0.12, respectively). Logistic regression adjusted for potential confounders further explained the relationship between craniotomy type and radiological infarction (large 1-piece/2-piece craniotomy: odds ratio, 3.1; 95% CI, 1.2-7.6; P=0.015). CONCLUSION: In combined revascularization of the ACA and MCA territories in moyamoya disease, 2-piece craniotomy may reduce the risk of postoperative cerebral infarction.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。